Author

D. Kroon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:mouse· 1 Research Focus:protein folding & dynamics· 1 Approach:statistical model· 1 Assay:structural biology· 1

Frequent Co-Authors

A. Jurgilaitis· 1 shared A. U. J. Bengtsson· 1 shared C. Frielink· 1 shared D. F. Boreel· 1 shared E. Oosterwijk· 1 shared G. Franssen· 1 shared G. Katona· 1 shared G. Tamborino· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiophysics

A. Jurgilaitis

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Femtosecond X-ray snapshots reveal correlated displacements of specific distal atoms in a protein crystal

V. A. Gagner, M. Jensen, T. N. Olsson, J. C. Sanchez, A. U. J. Bengtsson, J. C. Ekström, Z. Zhang, A. Jurgilaitis, D. Kroon, V.-T. Pham, S. Checchia, H. Coudert-Alteirac, H. Rodilla, J. Stake, V. Zhaunerchyk, , G. Katona

The paper uses femtosecond X-ray diffraction to study atomic displacements in bovine trypsin crystals, showing correlated movements influenced by THz pulses and atomic type.

bioRxiv · May 29, 2024 · PreprintBiophysics

Towards Effective CAIX-targeted Radionuclide and Checkpoint Inhibition Combination Therapy for Advanced Clear Cell Renal Cell Carcinoma

S. C. Kleinendorst, E. Oosterwijk, J. Molkenboer-Kuenen, C. Frielink, G. Franssen, D. F. Boreel, G. Tamborino, M. Gloudemans, M. Hendrikx, D. Kroon, J. Hillen, J. Bussink, S. Muselaers, P. Mulders, M. W. Konijnenberg, , S. Heskamp

This study investigates the combination of targeted radionuclide therapy and immune checkpoint inhibitors for advanced clear cell renal cell carcinoma, showing enhanced therapeutic outcomes and immune microenvironment changes.

bioRxiv · Feb 16, 2024Cancer Biology